Univariate analysis revealed significant differences between the 2 groups in several clinical parameters, including tumor size, clinical T stage, ER status, PR status, HER2 status, Ki-67 expression, breast cancer intrinsic subtype, CA15-3 levels, and hemoglobin concentrations. Here, MKI67 is linked to breast cancer.